Healthy Living Europe: Press Releases

Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Healthy Living Europe.

Press releases published on November 9, 2026

Nov. 9, 2026

Stanford Medicine Sutter Health Cancer Center expands access to advanced cancer care in the East Bay

Indeterminate GlobeNewswire

Nov. 9, 2026

Hinge Bio Shares Encouraging Clinical Data for HB2198, a Novel B-Cell Depleting Agent for Treating Autoimmune Disease, at ACR Convergence 2026

Indeterminate GlobeNewswire

Nov. 9, 2026

2026 state mental health rankings released by Mental Health America

Indeterminate GlobeNewswire

Nov. 9, 2026

TalkingParents Launches Service Appreciation Discount for Military Members and First Responders

Indeterminate GlobeNewswire

Nov. 9, 2026

Baylor Genetics to Highlight the Clinical Value of Genomics in Pediatric Care at the 2026 National Society of Genetic Counselors Annual Meeting

Indeterminate GlobeNewswire

Nov. 9, 2026

Cullinan Therapeutics to Participate in Upcoming Investor Conferences

Indeterminate GlobeNewswire

Nov. 9, 2026

Kraig Labs Ships Spider Silk to Developers Across Global Industries

Indeterminate GlobeNewswire

Nov. 9, 2026

Boehringer Ingelheim's survodutide is the first glucagon/GLP-1 dual agonist to demonstrate a favorable cardiovascular safety profile in global Phase III SYNCHRONIZE-CVOT trial alongside significant cardiometabolic benefits

Indeterminate GlobeNewswire

Nov. 9, 2026

Zealand Pharma announces Boehringer Ingelheim’s survodutide is the first glucagon/GLP-1 dual agonist to demonstrate a favorable cardiovascular safety profile in global Phase 3 SYNCHRONIZE-CVOT trial with significant cardiometabolic benefits

Indeterminate GlobeNewswire

Nov. 9, 2026

IDG Capital’s Consumer Investing Centers onThreeThemes: Brands, Transactions and Channels

Indeterminate EIN Presswire

Nov. 9, 2026

Oncovita Granted Orphan Drug Designation For MVdeltaC in Mesothelioma by the European Commission

Indeterminate GlobeNewswire

Nov. 9, 2026

Pelareorep Induces Coordinated Antiviral Immune Responses and Enhanced Antitumor Immunity in Multiple Myeloma Patients

Indeterminate GlobeNewswire

Nov. 9, 2026

USARAD, a Nanox Company, Expands Collaboration with AZmed to Integrate FDA-Cleared X-ray AI into Its Teleradiology Workflows

Indeterminate GlobeNewswire

Nov. 9, 2026

CRISPR Therapeutics Presents Phase 1b Data for CTX310® Demonstrating Reductions in ANGPTL3 and Triglycerides in Patients with Severe Hypertriglyceridemia at the American Heart Association (AHA) Scientific Sessions 2026

Indeterminate GlobeNewswire

Nov. 9, 2026

Park Dental Partners Completes Acquisition of Village Family Dental Support Services Organization, Expands into North Carolina

Indeterminate GlobeNewswire

Nov. 9, 2026

Daré Bioscience Releases Next Episode in “CEO Corner” Video Series

Indeterminate GlobeNewswire

Nov. 9, 2026

NorthSea Therapeutics Announces Positive Phase 2 Topline Data in First-ever Randomized Placebo-controlled Study of an Oral Therapy in Intestinal Failure-Associated Liver Disease

Indeterminate GlobeNewswire

Nov. 9, 2026

Cleveland Clinic Canada Moves to New Downtown Toronto Location

Indeterminate GlobeNewswire

Nov. 9, 2026

Curia Expands Fermentation Capacity in León, Spain

Indeterminate GlobeNewswire

Nov. 9, 2026

Curia baut Fermentationskapazitäten am Standort León in Spanien aus

Indeterminate GlobeNewswire